CDKN2B-AS1 and stroke disorder: MALAT1 and ANRIL (Yang et al., 2018; Tan et al., 2019; Fathy et al., 2021) were previously demonstrated to serve as protective or detrimental predicting factors for stroke under certain circumstances.